I'm glad you're on SR Tryptamine, I think you're serving a very useful purpose. In a small way certainly, but an important way nonetheless. I hope to see a diverse cadre of similar vendors supplying you with competition ;-)I am not referring to helping people potentially reduce headaches/lower energy levels/being dope sick etc, nor to the notion of validating SR's existence by virtue of being a vendor that sells legal products (legal, but that doesn't mean they're in malls). Those are worthy thoughts, but not the main thing.I think nootropics are going to become very, very big in the 21st century, and on balance result in huge dividends to the world. For the same reason that tiny companies often dance circles around larger and more powerful ones, I think black/grey-market empirical work will lead the way. The mainstream pharma and regulatory authorities are too sluggish to envision the possibilities, in the same sense that NASA technically has all the possible firepower and know-how to push at the limits, and yet somehow in practice has failed to do so for a very long time. If anything it's amazing they've achieved this much with so little, I don't intend to bash them too hard, their intentions were good and they are very far from stupid. But you know what they say about intentions. They are worthless, sad but true.Regulatory frameworks in particular, are frequently the death knell for scientific enterprise. Most major pharmaceutical companies today have one or two drugs that work, and a legion of copycat drugs and placebos. Whatever the reason, it is certain that progress has been retarded somehow for quite some time. People like Sasha Shulgin are rare, and it seems to me their incredible effectiveness at producing results has a hell of a lot to do with their unorthodox, often unique perspective. I mean, one Shulgin is worth ten or twenty thousand pharmacologists and I really mean that, it is literally that kind of disparity. Sometimes it's not about doing it right or wrong, or even thinking like Dr Shuglin (which would miss the point), but simply doing it differently.There's a host of intelligent young men and women in pharmacology and the medical sciences today, close to completely wasting their potential by too narrowly focusing on harm prevention and curatives. I see Nootropics, with respect to pharmacology, as being as fundamental as the invention of negative numbers or zero in mathematics. They are the other half of the picture, not a mere peripheral detail or curiosity for the more hypochondriac among us.It's not necessarily about actually inventing some new chemical either, a change of perspective in the scientific community and among practitioners is the majority of the battle. So; keep the ball rolling. Needless to say the demand is infinite and supply of good answers negligible, so there's always the potential for uber success, wealth and fame! Let me know if you eventually float an IPO :D